Agilent Technologies (A) Stock: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$167.78
1.10 (0.66%)
▲
5d:
-2.9%
30d:
+10.83%
90d:
+28.47%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 23, 2026
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: A shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: A shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$188.76
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$117.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $167.78, which is considered extended relative to its 30-day fair value range of $148.03 to $167.35. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.8) compared to its historical average (20.4). At these levels, the market is pricing in 6.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, A is in a strong uptrend. Immediate support is located at $157.08, while resistance sits at $177.05.
Market Sentiment: A scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, A is in a strong uptrend. Immediate support is located at $157.08, while resistance sits at $177.05.
Market Sentiment: A scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$148.03 -
$167.35
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
22.9%
Protect Your Profits
Holding A? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($175.20)
- NEUTRAL: Trading at premium valuation - market expects 6.8% growth which is achievable
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$148.03 -
$167.35
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$157.08
Resistance Level
$177.05
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.83
Wall Street Target
$175.20
(+4.4%)
Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
8.5%
Profit Margin
19.5%
Valuation Premium vs History
+6.8% premium
PE vs Historical
24.8 vs 20.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.8%
(market-implied from PE analysis)
1-Year Target
$179.19
(+7%)
2-Year Target
$191.37
(+14%)
3-Year Target
$204.39
(+22%)
3-Yr Target (if PE normalizes)
(PE: 25→20)
PE COMPRESSION
$167.95
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.8, Growth: 9.0%)
$217.22
(+30%)
Base:
(SPY PE: 20.4, Growth: 9.0%)
$178.49
(+6%)
Bear:
(PE: 17.3, Growth: 9.0%)
$151.71
(-10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 34.02 | Current EPS (TTM): $4.90
Bull Case
$252.87
(+51%)
Analyst growth 37.9%, PE expands to 37.4
Base Case
$229.89
(+37%)
Market implied 37.9%, PE stable at 34.0
Bear Case
$113.34
(-32%)
Severe decline -20.0%, PE contracts to 28.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 03, 2026 1:14 PM ET
Data refreshes hourly during market hours. Next update: 2:14 PM
Data refreshes hourly during market hours. Next update: 2:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 49 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 48 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 67 BUY |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
